A Win For NanoViricides, Inc.
Mon, Jan 27, 2020 at 05:30 PM
NanoViricides, Inc. (NNVC:NYSEMKT) rocketted at $15.8, a gain of 87%. On Fri 24 Jan 20, NNVC:NYSEMKT touched a New 2-Week Intraday High of $10.2. The stock appeared on our News Catalysts scanner on Mon 27 Jan 20 at 11:36 AM in the 'BIOTECH' category. From Fri 03 Jan 20, the stock recorded 57.14% Up Days and 60.00% Green Days
The stock spiked on Tue 21 Jan 20 at $13.45 with a volume of 4M+.
About NanoViricides, Inc. (NNVC:NYSEMKT)
Nanoviricides Inc is a development stage nano-biopharmaceutical company. Its business activities are to discover, develop and commercialize therapeutics to take care of patients suffering from life-threatening viral infections.
Top 10 Gainers:
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 210.61%
- Lianluo Smart Limited (LLIT:NASDAQ), 152.29%
- NanoViricides, Inc. (NNVC:NYSEMKT), 86.98%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 82.45%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 65.42%
- Miragen Therapeutics, Inc. (MGEN:NASDAQ), 50.52%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 50%
- Vaxart, Inc. (VXRT:NASDAQ), 30%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 28.33%
- Sophiris Bio, Inc. (SPHS:NASDAQ), 27.23%